Visual Neglect – Rehabilitation — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Inactive SPMS; this presentation falls outside the current NICE siponimod population
Explanation lettering: C = shown as B · D = shown as C · E = shown as D · B = shown as E
C is correct. NICE recommends siponimod for SPMS only with active disease, defined by relapses or imaging features of inflammatory activity. Disability progression confirms SPMS trajectory but does not by itself meet this activity definition. A conflates progression with inflammation. B is the wrong disease phenotype. D invents a surrogate. E invents an age exception.
Reference: NICE TA656 — siponimod for secondary progressive MS: https://www.nice.org.uk/guidance/ta656/chapter/1-Recommendations